IP Verse

Ametropia Treatment Tracking Methods And System

EP3395233

JOHNSON & JOHNSON VISION CARE, INC.
Application Number
EP18168950A
Filing Date
Apr 24, 2018
Status
Granted And Under Opposition
Mar 18, 2022
Grant Date
Apr 20, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3395233B1 was granted on Apr 20, 2022 by Johnson & Johnson Vision Care, Inc. The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LUMI IP GMBHJan 20, 2023ADMISSIBLE

More Opposed Patents of Johnson & Johnson Vision Care, Inc.

The table below shows the patents of Johnson & Johnson Vision Care, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP4049580Ametropia Treatment Tracking Methods And SystemSep 6, 20231
EP2349698Binder Of Energized Components In An Ophthalmic LensJan 18, 20231
EP2778764Method And Apparatus For Encapsulating A Rigid Insert In A Contact Lens For Correcting Vision In Astigmatic PatientsNov 2, 20221

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents